[Skip to Content]
[Skip to Content Landing]
Citations 0
Letters
December 20, 2000

Health Consequences of Eclipse Cigarettes—Reply

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Executive Deputy EditorIndividualAuthor

JAMA. 2000;284(23):2995-2996. doi:10.1001/jama.284.23.2993

In Reply: Drs Burger and Swauger do not substantively address any of the major criticisms of R. J. Reynolds' new Eclipse brand cigarette.1 First, the only appropriate body to evaluate and regulate nicotine delivery devices, including Eclipse, is the US Food and Drug Administration (FDA)—the only entity with the expertise, objectiveness, and appropriate authority to determine whether, and on what terms, such devices should be available in the marketplace. Pharmaceutical companies must meet rigorous scientific review and approval by the FDA before they market nicotine replacement devices such as gum, patch, and nasal spray. The public is unaware that Eclipse, like other tobacco products, remains unregulated merely because a tobacco company manufactures it and wraps it in white paper to look like a cigarette. Notably absent from the authors' comments is any discussion as to why Eclipse "cigarettes" should not be considered smoke-flavored nicotine delivery devices, subject to jurisdiction by the FDA, as we believe they should be.

First Page Preview View Large
First page PDF preview
First page PDF preview
×